These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37932184)

  • 1. Deciphering the True Immunologic Risk in Renal Transplantation in Patients With HIV.
    Kahler D; Curtis H; Zhao H; Diamond A; Di Carlo A; Karhadkar S
    Transplant Proc; 2023 Dec; 55(10):2392-2397. PubMed ID: 37932184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB; Orandi BJ; Waldram MM; Luo X; Nguyen AQ; Montgomery RA; Lentine KL; Segev DL
    Am J Kidney Dis; 2020 Nov; 76(5):616-623. PubMed ID: 32668318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater Impact of Living Donation Than HLA Mismatching in Short-Term Renal Allograft Survival.
    Ribeiro B; Reis Pereira P; Oliveira J; Almeida M; Martins S; Malheiro J
    Cureus; 2023 Jan; 15(1):e34427. PubMed ID: 36733571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deceased vs. living donor kidney transplantation in prediction of acute renal allograft rejection using Tc-99m DTPA renal scan.
    Cho SG; Choi SJN; Park KS; Kim J; Moon JB; Song HC
    Ann Nucl Med; 2020 Nov; 34(11):847-855. PubMed ID: 32918204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes of living and deceased donor kidney grafts surviving longer than 5 years in Korea.
    Lee S; Kim J; Shin M; Kim E; Moon J; Jung G; Choi G; Kwon C; Joh J; Lee S; Kim S
    Transplant Proc; 2010 Apr; 42(3):775-7. PubMed ID: 20430168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of De Novo Donor Specific Antibody Based on the Type of Kidney Transplantation.
    Park WY; Kim Y; Paek JH; Jin K; Han S
    Transplant Proc; 2022 Mar; 54(2):335-340. PubMed ID: 35101323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time.
    Koo TY; Lee JH; Min SI; Lee Y; Kim MS; Ha J; Kim SI; Ahn C; Kim YS; Kim J; Huh KH; Yang J
    Kidney Int; 2021 Jul; 100(1):206-214. PubMed ID: 33647326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential impact of size mismatch in live versus deceased donor kidney transplant.
    Vinson A; Skinner T; Kiberd B; Clark D; Tennankore K
    Clin Transplant; 2021 Jun; 35(6):e14310. PubMed ID: 33818840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of dialysis and the transplantation options for patients with diabetic end-stage renal disease in Korea.
    Jeon HJ; Koo TY; Han M; Kim HJ; Jeong JC; Park H; Ha J; Kim SJ; Ahn C; Park JB; Yang J
    Clin Transplant; 2016 May; 30(5):534-44. PubMed ID: 26914661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients.
    Lee H; Lee H; Eum SH; Ko EJ; Min JW; Oh EJ; Yang CW; Chung BH
    Ann Lab Med; 2023 Jul; 43(4):364-374. PubMed ID: 36843405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of ABO-incompatible kidney transplantation in older patients: a national cohort study.
    Kim DG; Lee J; Kim MS; Kwon OJ; Jung CW; Lee KW; Yang J; Ahn C; Huh KH;
    Transpl Int; 2021 Feb; 34(2):290-301. PubMed ID: 33258121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database.
    Young BY; Gill J; Huang E; Takemoto SK; Anastasi B; Shah T; Bunnapradist S
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):845-52. PubMed ID: 19201918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pretransplant dialysis vintage on clinical outcomes in deceased donor kidney transplant.
    Lim JH; Jeon Y; Kim DG; Kim YH; Kim JK; Yang J; Kim MS; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Cho JH;
    Sci Rep; 2022 Oct; 12(1):17614. PubMed ID: 36271226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of pediatric living donor kidney transplantation: A single-center experience.
    Pérez-Bertólez S; Barrero R; Fijo J; Alonso V; Ojha D; Fernández-Hurtado MÁ; Martínez J; León E; García-Merino F
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28133940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation in children and adolescents: an analysis of United Network for Organ Sharing Database.
    Hardy BE; Shah T; Cicciarelli J; Lemley KV; Hutchinson IV; Cho YW
    Transplant Proc; 2009 Jun; 41(5):1533-5. PubMed ID: 19545673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and Graft Loss Attributable to Readmission After Kidney Transplantation: Immediate and Long-term Risk.
    King EA; Bowring MG; Massie AB; Kucirka LM; McAdams-DeMarco MA; Al-Ammary F; Desai NM; Segev DL
    Transplantation; 2017 Oct; 101(10):2520-2526. PubMed ID: 27941434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.